243 participants
A Study to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel Versus Placebo + Trastuzumab + Docetaxel in Previously Untreated Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-12-16
- Start Date:
- 2016-09-13
- Completion:
- 2018-06-27
Conditions
- Breast Cancer
Interventions
- DRUG